Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence GGPGGAGVARGGAGGGP
Primary information
sequence IDSeq_2689
Peptide sequenceGGPGGAGVARGGAGGGP
CancerPDF_ID CancerPDF_ID2177, CancerPDF_ID9852, CancerPDF_ID12753,
PMID21136997,21533267,27058005
Protein NameNeurogranin,Neurogranin,Neurogranin
UniprotKB Entry NameNEUG_HUMAN,NEUG_HUMAN,NEUG_HUMAN
FluidSerum,Serum,Serum
M/Z1250.6116,626.31,1251.732
Charge1,2,NA
Mass (in Da)NA,NA,NA
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,MALDI-TOF
Peptide Identification techniqueLC-MS-MS/MS,LC/MS/MS,LC-MS/MS
Quantification TechniqueLC-ESI-MS,Multiple Reaction Monitoring,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDRNA,1.49,NA
CancerPDF_ID CancerPDF_ID2177, CancerPDF_ID9852, CancerPDF_ID12753,
p-ValueNA,NA,"0.056,0.347,0.242"
SoftwareMASCOT(v. 2.2.01),MASCOT,Proteome Discoverer
Length17,17,17
Cancer TypeColorectal cancer,Lung adenocarcinoma,Breast cancer
DatabaseSwissProt Database,Swissprot Database (57.4),SwissProt Database
ModificationNA,NA,NA
Number of Patients30 patients and 30 healthy controls,62 lung adenocarcinoma and 30 healthy control," 28 were diagnosed with Breast cancer, 27 remained cancer-free with BRCA carrier. Of the remaining patients, 39 were diagnosed with sporadic breast cancer (SBC), and 38 were healthy volunteers (WT)."
RegulationNA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal","Upregulated with the fold change of 1.16 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.07, Upregulated in BC vs healthy with 1.103 fold change"
ValidationLeave One out Cross validation,MRM-based validation of 19 candidates,NA
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB